Pharma Aids Limited

(Q3 Un-audited): EPS was Tk. 6.11 for January-March 2026 as against Tk. 4.45 for January-March 2025; EPS was Tk. 20.20 for July 2025-March 2026 as against Tk. 15.77 for July 2024-March 2025. NOCFPS was Tk. 13.00 for July 2025-March 2026 as against Tk. 5.58 for July 2024-March 2025. NAV per share was Tk. 155.55 as on March 31, 2026 and Tk. 138.58 as on June 30, 2025. (cont.)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2026 at 3:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.

The Company has informed that 149,500 shares held by Late M. A. Masud, a Sponsor Director and former Chairman of the Company, who passed away on 11.11.2025, will be transmitted among his successors in accordance with the Succession Certificate issued by the Honorable Court. The names of the successors, their relationships with the deceased shareholder, and the number of shares to be received by each successor are as follows: (cont.)